We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Soy Peptides (soy protein hydrolysate bioactive peptides; incl. lunasin)
Short, bioactive fragments enzymatically cleaved from soy protein — soy protein hydrolysates plus named peptides like lunasin and soy ACE-inhibitory peptides. Unlike whole soy protein (a complete protein with an FDA cholesterol claim) or soy isoflavones (phytoestrogens), these are specific peptide fragments studied for cholesterol, blood pressure and antioxidant effects. Honest appraisal: the evidence is mostly in-vitro and animal. The one published human RCT (lunasin) was null. Emerging, not established.
What the evidence says
Most Soy Peptides studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2007–2026 with a typical study size of 31 participants.
Based on 16 studies · 3 RCTs · 31 total participants
Confidence
Moderate confidenceBy outcome
Mechanisms for cholesterol, blood-pressure, and antioxidant effects are well-characterized in cell and enzyme models, but the single published human RCT was null, keeping evidence Emerging.
10 trials ongoing or recruiting · 90 completed on ClinicalTrials.gov
6 of the completed trials have posted results
Registered trials show research momentum for Soy Peptides, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Soy peptides are short amino-acid sequences released from soy (Glycine max) protein by enzymatic hydrolysis, fermentation, or gastrointestinal digestion.
This entry is specifically about those bioactive *peptide fragments* — soy protein hydrolysates and named peptides such as lunasin (a 43-amino-acid seed peptide) and soy ACE-inhibitory peptides — and is deliberately distinct from the site's separate 'soy protein' entry (whole, intact protein dosed in grams for muscle and cholesterol, carrying the FDA heart-health claim) and 'soy isoflavones' entry (phytoestrogen non-protein compounds).
Critically, the bioactive-peptide fraction is largely separable from isoflavones: one mechanistic study explicitly showed that an isoflavone-containing ethanol extract did NOT stimulate LDL-receptor transcription, whereas the peptide fraction did — so isolated soy peptides carry a low estrogenic load compared with whole soy.
The proposed mechanisms are plausible and well-characterized in the dish: soy peptides inhibit angiotensin-converting enzyme (ACE) in vitro (suggesting a blood-pressure angle), up-regulate hepatic LDL-receptor transcription (a hypocholesterolemic angle distinct from isoflavones), and scavenge free radicals / reduce reactive oxygen species (an antioxidant angle).
Lunasin specifically has antioxidant, anti-inflammatory, and endothelial-protective effects in cell and animal models. But the honest evidence picture is thin and front-loaded with preclinical work.
The single published human trial — a triple-blind placebo-controlled crossover of lunasin-enriched soy extract (335 mg/day, 8 weeks) in 31 adults — found NO significant change in cholesterol, glucose, insulin, blood pressure, or body composition, and its authors called for higher doses and larger samples.
Most of the cholesterol, blood-pressure, and antioxidant claims therefore rest on cell, enzyme-assay, and rodent data, not on controlled human outcomes. The overall evidence is emerging.
Soy protein hydrolysate fractions and lunasin-derived fragments inhibit angiotensin-converting enzyme in enzyme assays (e.g. the peptide NDRP, IC50 ~148 μg/mL), the same target class as antihypertensive drugs — but this is shown in vitro, not yet in human blood-pressure trials.
Soybean protein hydrolysate peptides stimulate hepatic LDL-receptor (LDL-R) transcription in liver-cell models, a cholesterol-clearance mechanism. Notably the isoflavone-containing fraction did NOT do this — the activity tracks the peptides, distinguishing it from soy isoflavones.
Lunasin and soy peptide fractions scavenge peroxyl, superoxide, DPPH and ABTS radicals and reduce reactive oxygen species in cell models, protecting against oxidative damage in vitro.
In cell models lunasin suppresses ox-LDL-induced monocyte adhesion to endothelial cells (via KLF2/eNOS) and dampens NF-κB inflammatory signalling — an early-atherosclerosis-relevant mechanism, but entirely preclinical.
How Soy Peptides works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Contraindicated — avoid entirely.
Generally safe; monitor blood pressure given the theoretical additive effect.
Soy as a food is part of normal diets; isolated soy-peptide supplements are not specifically studied in pregnancy. The isoflavone/estrogenic load of the isolated peptide fraction is low, so the food-derived peptides are likely safe at dietary-level intakes, but supplement-level data are lacking.
Soy peptides inhibit ACE in vitro; a theoretical additive blood-pressure-lowering effect with antihypertensive medication, though no clinically meaningful human interaction has been demonstrated.
Soy protein products can interfere with thyroid-hormone absorption; separate dosing if taken alongside soy-derived ingredients.
Tip: Avoid entirely if soy-allergic
Tip: Take with food; reduce dose
Tip: Inherent to protein hydrolysates; mask in food/beverage
Soy Peptides has an evidence score of 3/10 — emerging evidence based on 11 indexed studies. Short, bioactive fragments enzymatically cleaved from soy protein — soy protein hydrolysates plus named peptides like lunasin and soy ACE-inhibitory peptides. Unlike whole soy protein (a complete protein with an FDA cholesterol claim) or soy isoflavones (phytoestrogens), these are specific peptide fragments studied for cholesterol, blood pressure and antioxidant effects. Honest appraisal: the evidence is mostly in-vitro and animal. The one published human RCT (lunasin) was null. Emerging, not established. Representative study: PMID 36461277.
The commonly studied dose of Soy Peptides is No validated human dose. The single lunasin RCT used 335 mg/day of lunasin-enriched soy extract; soy protein hydrolysate ingredients are typically used at ~1-6 g/day, but no efficacious human regimen is established.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Soy Peptides is with meals. Take it with food. Food-derived peptides are typically taken with meals; no validated optimal schedule exists.
Soy Peptides is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are bitter taste, allergic reaction (in soy-allergic individuals), GI upset / bloating. Use caution if any of these apply to you: Soy allergy (absolute — soy is a major allergen); Known hypersensitivity to soy protein.
Magnesium
Probably helpsSupports 300+ enzymatic reactions — critical for sleep, stress response, muscle function, and cognitive health.
Berberine
Likely helpsActivates AMPK to regulate blood sugar, improve insulin sensitivity, and support lipid metabolism — comparable to metformin in some trials.
Cinnamon
Mostly mechanism / observationalA polyphenol-rich spice studied mainly for modest improvements in blood sugar and blood lipids; choose Ceylon to limit coumarin.
Pectin
Mostly mechanism / observationalA viscous soluble fiber from apple and citrus that forms a gel in the gut — modestly lowers LDL/total cholesterol, blunts post-meal glucose, and feeds gut bacteria.
Explore: Best supplements for Vitality & Longevity
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 16 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research